A
$ Value
$0
Shares
28,500
Price
$0
Filed
Jun 6
Insider
Name
Collins Helen Louise
Title
—
CIK
0001701247
Roles
Director
Transaction Details
Transaction Date
2025-06-05
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
28,500
Footnotes
This option vests in full on the one year anniversary of the date of grant.
Filing Info
Collins Helen Louise's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-17 | ELVN | M | $12K |
| 2026-04-17 | ELVN | ▼ | $6K |
| 2026-04-17 | ELVN | ▼ | $115K |
| 2026-04-17 | ELVN | ▼ | $117K |
| 2026-04-17 | ELVN | M | $0 |
| 2026-03-25 | ELVN | M | $99K |
| 2026-03-25 | ELVN | ▼ | $1.4M |
| 2026-03-25 | ELVN | M | $0 |
| 2026-02-17 | ELVN | M | $112K |
| 2026-02-17 | ELVN | ▼ | $1.2M |
Other Insiders at KURA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
WILSON TROY EDWARD
President and CEO
|
— | — | 2026-03-23 |
|
FORD KATHLEEN
Chief Operating Officer
|
— | $15K | 2026-01-27 |
|
Bair Teresa Brophy
Chief Legal Officer
|
— | $95K | 2026-01-27 |
|
DOYLE THOMAS JAMES
SVP, Finance & Accounting
|
— | $60K | 2026-01-27 |
|
Powl Brian T.
Chief Commercial Officer
|
— | $54K | 2026-01-27 |
|
Leoni Mollie
Chief Medical Officer
|
— | $69K | 2026-01-27 |
|
Burrows Francis
Chief Scientific Officer
|
— | $11K | 2026-01-27 |